Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:44 PM
Ignite Modification Date:
2025-12-24 @ 6:44 PM
NCT ID:
NCT04370457
Eligibility Criteria:
Inclusion Criteria:
1. Adults (≥18 years)
2. Diagnosed with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) or myelodysplastic syndrome (MDS)
3. Scheduled to receive any line of treatment for CLL/SLL or MDS or who have been previously exposed to any treatment for CLL or MDS
4. Able to understand and communicate in the respective language
5. Users of an Internet connected device (smart phone/tablet)
Exclusion Criteria:
1. Patients who are already participating in another experimental study
2. Patients needing immediate referral for specialized palliative care
3. Any life-threatening illness, medical condition, or organ system dysfunction that, in the investigator's opinion, could compromise the subject's safety or put the study outcomes at undue risk
4. Patients unable to provide written informed consent
5. Life expectancy \<3 months
6. For CLL cohort: patients who have experienced Richter transformation
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT04370457
Study Brief:
Protocol Section:
NCT04370457